Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug shows promise for shingles nerve pain

NCT ID NCT04662281

First seen Feb 20, 2026 · Last updated Jun 18, 2026 · Updated 18 times

Summary

This study tested an experimental drug called LX9211 in 79 adults with postherpetic neuralgia, a type of nerve pain that can last for months after a shingles rash heals. The goal was to see if the drug reduces pain and helps with sleep compared to a placebo over 11 weeks. Participants had moderate to severe pain for at least 3 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTHERPETIC NEURALGIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Lexicon Investigational Site

    Scottsdale, Arizona, 85258, United States

  • Lexicon Investigational Site

    Tucson, Arizona, 85741, United States

  • Lexicon Investigational Site

    Greenbrae, California, 94904, United States

  • Lexicon Investigational Site

    Brandon, Florida, 33511, United States

  • Lexicon Investigational Site

    Miami, Florida, 33144, United States

  • Lexicon Investigational Site

    Miami, Florida, 33174, United States

  • Lexicon Investigational Site

    Ormond Beach, Florida, 32174, United States

  • Lexicon Investigational Site

    Winter Park, Florida, 32789, United States

  • Lexicon Investigational Site

    Flossmoor, Illinois, 60422, United States

  • Lexicon Investigational Site

    Wauconda, Illinois, 60084, United States

  • Lexicon Investigational Site

    Boston, Massachusetts, 02131, United States

  • Lexicon Investigational Site

    Canton, Michigan, 48187, United States

  • Lexicon Investigational Site

    Hazelwood, Missouri, 63042, United States

  • Lexicon Investigational Site

    Albuquerque, New Mexico, 87102, United States

  • Lexicon Investigational Site

    Jenkintown, Pennsylvania, 19046, United States

  • Lexicon Investigational Site

    Baytown, Texas, 77521, United States

  • Lexicon Investigational Site

    Victoria, Texas, 77901, United States

  • Lexicon Investigational Site

    Salt Lake City, Utah, 84102, United States

  • Lexicon Investigational Site

    Kenosha, Wisconsin, 53144, United States

  • Lexicon Investigational Site (113)

    Miami, Florida, 33032, United States

  • Lexicon Investigational Site (128)

    Katowice, 40-282, Poland

  • Lexicon Investigational Site (130)

    Katowice, 640-748, Poland

  • Lexicon Investigational Site (133)

    Warsaw, 01-868, Poland

  • Lexicon Investigational Site (134)

    Lublin, 20-064, Poland

  • Lexicon Investigational Site (135)

    Prague, 16000, Czechia

  • Lexicon Investigational Site (136)

    Prague, 100 00 00, Czechia

  • Lexicon Investigational Site (137)

    Prague, 12000, Czechia

  • Lexicon Investigational Site (138)

    Choceň, 565 01, Czechia

  • Lexicon Investigational Site (140)

    Pardubice, 53002, Czechia

  • Lexicon Investigational Site (141)

    Prague, 13000, Czechia

  • Lexicon Investigational Site (147)

    Marietta, Georgia, 30060, United States

  • Lexicon Investigational Site (148)

    Cary, North Carolina, 27518, United States

Conditions

The condition(s) this trial relates to.

Neuralgia, Postherpetic postherpetic neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.